REVON Systems retweeted
And of course we talked about cannabis! mmm-online.com/home/channel/…
REVON Systems retweeted
Sedgwick et al., bioinformatics 2019 at TOPMed; finding subgroups of COPD using probabilistic graph models; talk by Panagiotis Benos from UPittsburgh with relevance to dementia heterogeneity..
REVON Systems retweeted
The problem is not the #innovation of building of new #app, the problem is the distribution channel, says @atreja at #mcINVEST
REVON Systems retweeted
The value of #ai in the field of COPD is well explained by Christopher Carlin from NHSGGC Thx @KenSci for great work #Microsofthealthcarestories #svmed
REVON Systems retweeted
"The Exposome and Asthma" by Ahila Subramanian and Sumita B. Khatri (@SumitaKhatri; @ClevelandClinic). Read @sciencedirect and at: chestmed.theclinics.com/arti…
REVON Systems retweeted
Report: Digital #Respiratory Market is Still at an Emerging Stage bit.ly/2Ewz2f2 #digitalhealth #asthma #connectedhealth
REVON Systems retweeted
Humana is talking to a company called Babylon that uses AI in third world countries to help deliver health care. That’s an interesting trend to watch.
REVON Systems retweeted
Creating a Digital Superhighway for Clinical Trials
businesswire.com/news/home/2… @OchsnerHealth
REVON Systems retweeted
New COPD treatment at UofL Hospital is a 'landmark development' bit.ly/2SddIDD
REVON Systems retweeted
Great information from @uofl pulmonologists Drs. Umair Gauhar and Hiram Rivas from @UofL_PCCS 🔬📺 #WeAreUofL
We loved him in 'Ghost'!
At #SSTS19 Chip Parkinson from @myriadgenetics led a Cambia Grove roundtable discussion on "Using Technology to Improve Health," joined by @RegenceUtah President Jim Swayze. Learn more about the #health #innovation ecosystem in Utah here: bddy.me/2RKx8Le
REVON Systems retweeted
Proud to be on a team endorsed by @Sanofi, @UCB_news, @MCK_Ventures, @HorizonBCBSNJ and @Amgen as strategic investors supporting Aetion’s vision for #realworldevidence and fixing healthcare. #realworlddata
REVON Systems retweeted
Sanofi's Reed notes that with wearables and continuous real-time data collection, it opens door to whole new mode of clinical evidence gathering. "Control arms could be a thing of the past," he said #BIGAxisSummit @PureTechH
"The Future of #Asthma Care: Personalized Asthma Treatment sciencedirect.com/science/ar…" via @sciencedirect.
REVON Systems retweeted
Right here in the 'ville, @ScottWMedTech.
"Louisville-area medical device company [@liberatemed] gets FDA breakthrough designation bizjournals.com/louisville/n…;" @BFLouChris.
"Report: Digital respiratory health market primed for growth, could reach $557M by 2023 shar.es/amnp18" via @MobiHealthNews.
"Both patients and clinicians found that @Epharmix’s EpxCOPD made a difference in patient care medcitynews.com/2019/01/epxc…;" @medcitynews.
REVON Systems retweeted
Are investors giving #respiratory #innovation enough attention? RIS Co-Chair Cecilia Gonzalo answers that question in this latest installment of Why RIS? Thursday is the final day to secure the early registration discount! Go to attendris.com. buff.ly/2CoHRVZ
REVON Systems retweeted
Peer-review me: #Wearable finger pulse oximetry for continuous oxygen saturation measurements during daily home routines of #Patients with COPD during a 1-week observational #Study dlvr.it/QwpZsK (preprint)
REVON Systems retweeted
.@PropellerHealth, whose acquisition by @ResMed closed last week, raised the most #venture capital of any #Wisconsin #startup in 2018. Learn more about this & the other big #Midwest rounds — via our MD @PeteWilkins_ for @VentureBeat: bit.ly/2slRmQS